Company: PAII-WT
Filing Date: 2025-06-27
Form Type: S-1
Source: 0001213900-25-059054
Chunk: 367

Company: Pyrophyte Acquisition Corp. II
Filing Date: 2025-06-27
Form: S-1
Chunk 367
---
 mentioned factors, or

| F-15 |

| Pyrophyte Acquisition Corp. II               
 Notes to financial statements                
 NOTE 6—COMMITMENTS AND CONTINGENCIES (cont.) |

any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel -Hamasconflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial business combination and any target business with which it may ultimately consummate an initial business combination. Registration rights The holders of the founder shares, private placement warrants (and their underlying securities) and units that may be issued upon conversion of working capital loans (and their underlying securities) and any Class A ordinary shares held by the Company’s initial shareholders at the completion of this offering or acquired prior to or in connection with the initial business combination, will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of the registration statement of which this prospectus forms a part, requiring the Company to register such securities for resale (in the case of the founder shares, only after conversion to Class A ordinary shares). The holders of these securities, having a value of at least $25 million in the aggregate, are entitled to make up to three demands that the Company offer such securities in an underwritten offering. These holders also have certain “piggyback” registration rights with respect to certain underwritten offerings the Company may conduct. The Company will bear the expenses incurred in connection with registering these securities. Underwriting agreement The underwriters will be entitled to an underwriting discount of $0.15 per unit on the 17,500,000 units being sold in the initial public offering, payable upon the consummation of the initial public offering. As such, the underwriters will be entitled to an underwriting discount of $2,625,000, payable upon the closing of this offering. In addition, $0.45 per unit sold in this offering, or $7,875,000 in the aggregate, will be payable for deferred underwriting commissions to be placed in a trust account located in the United States and released to UBS only upon the completion of an initial business combination. The underwriters have a 45 -dayoption from the date of this offering to purchase up to an additional 2,625,000 units to cover over -allotments, if any. If the underwriters’ over -allotmentoption is exercised, $0.60